ERBB3 and breast cancer: In addition to brain metastases derived from a primary breast cancer, which can overexpress HER3 [42, 43], increased HRG production by the stromal cells within the brain microenvironment may also result in activation of HER3 and its downstream signaling, thereby promoting breast cancer brain metastasis [41, 42, 44].